SPP1 and pulmonary arterial hypertension: In PAH patients, baseline circulating osteopontin levels predicted survival [51,52,53] and increased with worsening of the disease condition as assessed by six-minute walking distance (6MWD) [50,51] and New York Heart Association Functional Classification (NYHA-FC) [51,52].